Uniplan Investment Counsel’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Uniplan Investment Counsel's AMGN Position: Q2 2026 in Review
Uniplan Investment Counsel increased its Amgen (AMGN) stake by 29% in Q2 2026, buying an estimated $977K and bringing the position to 12,531 shares worth $4.54M. The position accounts for 0.43% of the portfolio, ranked #68.
Uniplan Investment Counsel first reported a position in AMGN in Q4 2023 and has held it in 11 quarters since. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Uniplan Investment Counsel held 12,531 shares of Amgen worth $4.54M as of Q2 2026.
- Uniplan Investment Counsel bought 2,854 Amgen shares in Q2 2026, an estimated $977K.
- Amgen made up 0.43% of Uniplan Investment Counsel's portfolio in Q2 2026, its #68 holding.
- Uniplan Investment Counsel first reported a position in Amgen in Q4 2023 and has held it in 11 quarters since.
- 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Uniplan Investment Counsel's 13F filing for Q2 2026, filed 13 Aug 2026.